中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(11): 2272-2277

Value of prealbumin-to-total bilirubin ratio in predicting the short-term prognosis of patients with HBV-related acute-on-chronic liver failure

DOI: 10.12449/JCH251112

  • Department of Infectious Diseases，The First Affiliated Hospital of Soochow University，Suzhou，Jiangsu 215000，China

Research funding:

National Key Science and Technology Special Project for the 13th Five-Year Plan (2017ZX10203201002-002);

China Hepatitis Prevention and Control Foundation Special Project (TGQB20180371)

More Information
  • Corresponding author: HUANG Xiaoping， grehxp@163.com （ORCID： 0000-0003-0916-2885）
  • Received Date: 2025-04-25
  • Accepted Date: 2025-07-16
  • Published Date: 2025-11-25
    Abstract
  •   Objective  To investigate the value of prealbumin-to-total bilirubin （PA/TBil） ratio on admission in predicting 90-day mortality or liver transplantation in patients with HBV-related acute-on-chronic liver failure （HBV-ACLF）， as well as the effect of its combination with Model for End-Stage Liver Disease （MELD） score on the predictive performance for short-term prognosis.  Methods  A retrospective analysis was performed for the clinical data of 216 HBV-ACLF patients who were admitted to Department of Infectious Diseases in the First Affiliated Hospital of Soochow University from April 2020 to May 2025， and the patients were followed up for 3 months. According to the outcome， the patients were divided into survival group with 104 patients and death/transplantation group with 112 patients. The Kolmogorov-Smirnov test was used to check whether the continuous data was in accordance with the normal distribution； the two-independent-samples t test was used for comparison of normally distributed continuous data between two groups， while the Mann-Whitney U test was used for comparison of continuous data with skewed distribution between two groups. The chi-square test was used for comparison of categorical data between two groups. Univariate and multivariate binary Logistic regression analyses were used to investigate the influencing factors for prognosis， and the receiver operating characteristic （ROC） curve was used to analyze the performance of each indicator in predicting the prognosis of ACLF. The area under the ROC curve （AUC） was calculated， and the Delong test was used for comparison of AUC.  Results  A total of 216 patients were enrolled in this study， with a 90-day survival rate of 48.15% （104/216）. Compared with the death/transplantation group， the survival group had significantly higher platelet count， lymphocyte count， albumin， and PA/TBil ratio （all P<0.05） and significantly lower age， white blood cell count， neutrophil count， prothrombin time， international normalized ratio， aspartate aminotransferase， total bilirubin， creatinine， and MELD score （all P<0.05）. The multivariate Logistic regression analysis showed that age （odds ratio ［OR］=1.05， 95% confidence interval ［CI］： 1.02 — 1.09， P<0.001）， PA/TBil ratio （OR=0.16， 95%CI： 0.05 — 0.46， P<0.001）， and MELD score （OR=1.09， 95%CI： 1.01 — 1.17， P=0.024） were independent influencing factors for 90-day prognosis in HBV-ACLF patients. PA/TBil ratio and MELD score used alone or in combination had an AUC of 0.760， 0.779， and 0.811， respectively， in predicting the prognosis of HBV-ACLF patients， and PA/TBil ratio combined with MELD score had a better AUC than PA/TBil ratio or MELD score used alone （Z=-2.058 and 2.017， both P<0.05）.  Conclusion  Both serum PA/TBil ratio and MELD score can effectively predict the prognosis of patients with HBV-ACLF， and a combination of the two indicators had a better predictive performance than MELD score alone， which provides an important reference for clinical risk stratification management and timely intervention.

     

    • FullText(HTML)
  • loading
    • References(32)
  • [1]
    ARROYO V, MOREAU R, JALAN R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382( 22): 2137- 2145. DOI: 10.1056/nejmra1914900.
    [2]
    PERRICONE G, ARTZNER T, de MARTIN E, et al. Intensive care management of acute-on-chronic liver failure[J]. Intensive Care Med, 2023, 49( 8): 903- 921. DOI: 10.1007/s00134-023-07149-x.
    [3]
    ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2021, 3( 1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
    [4]
    SHI K, ZHANG Y, LI YQ, et al. High-density lipoprotein cholesterol as a prognostic marker for 90-day transplant-free mortality in hepatitis B virus-related acute-on-chronic liver failure[J]. Front Cell Infect Microbiol, 2024, 14: 1458818. DOI: 10.3389/fcimb.2024.1458818.
    [5]
    CAI Q, WANG H, ZHU MY, et al. Construction of a novel prognostic scoring model for HBV-ACLF liver failure based on dynamic data[J]. Sci Rep, 2024, 14( 1): 15198. DOI: 10.1038/s41598-024-63900-4.
    [6]
    HUANG ZW, ZHANG G, LIU J, et al. LRFNet: A deep learning model for the assessment of liver reserve function based on Child‐Pugh score and CT image[J]. Comput Meth Programs Biomed, 2022, 223: 106993. DOI: 10.1016/j.cmpb.2022.106993.
    [7]
    RUF A, DIRCHWOLF M, FREEMAN RB. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane[J]. Ann Hepatol, 2022, 27( 1): 100535. DOI: 10.1016/j.aohep.2021.100535.
    [8]
    JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33( 6): 550- 558. DOI: 10.1200/JCO.2014.57.9151.
    [9]
    LIAO YY, TENG CL, PENG NF, et al. Serum prealbumin is negatively associated with survival in hepatocellular carcinoma patients after hepatic resection[J]. J Cancer, 2019, 10( 13): 3006- 3011. DOI: 10.7150/jca.30903.
    [10]
    HUO RR, LIU HT, DENG ZJ, et al. Dose-response between serum prealbumin and all-cause mortality after hepatectomy in patients with hepatocellular carcinoma[J]. Front Oncol, 2020, 10: 596691. DOI: 10.3389/fonc.2020.596691.
    [11]
    YIN Y, CHENG JW, CHEN FY, et al. A novel preoperative predictive model of 90-day mortality after liver resection for huge hepatocellular carcinoma[J]. Ann Transl Med, 2021, 9( 9): 774. DOI: 10.21037/atm-20-7842.
    [12]
    DUAN RX, LIU L, WANG Y, et al. Prognostic value of combined detection of alpha-fetoprotein, plasma prothrombin activity, and serum prealbumin in acute-on-chronic liver failure[J]. World J Gastrointest Surg, 2025, 17( 2): 99531. DOI: 10.4240/wjgs.v17.i2.99531.
    [13]
    FAN WH, LIAO W, LUO YP, et al. Clinical prediction for outcomes of patients with acute-on-chronic liver failure associated with HBV infection: A new model establishment[J]. Open Med, 2020, 15( 1): 714- 722. DOI: 10.1515/med-2020-0207.
    [14]
    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [15]
    YE QX, HUANG JF, XU ZJ, et al. Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure[J]. World J Clin Cases, 2022, 10( 23): 8186- 8195. DOI: 10.12998/wjcc.v10.i23.8186.
    [16]
    KIM WR, MANNALITHARA A, HEIMBACH JK, et al. MELD 3.0: The model for end-stage liver disease updated for the modern era[J]. Gastroenterology, 2021, 161( 6): 1887- 1895. e 4. DOI: 10.1053/j.gastro.2021.08.050.
    [17]
    ARTRU F, TROVATO F, MORRISON M, et al. Liver transplantation for acute-on-chronic liver failure[J]. Lancet Gastroenterol Hepatol, 2024, 9( 6): 564- 576. DOI: 10.1016/S2468-1253(23)00363-1.
    [18]
    LAI M, XU MM, WANG X, et al. Prognostic evaluation of liver transplantation for acute-on-chronic liver failure[J]. Ogran Transplant, 2025, 16( 3): 482- 488. DOI: 10.12464/j.issn.1674-7445.2025002.

    赖曼, 徐曼曼, 王鑫, 等. 慢加急性肝衰竭肝移植预后评估[J]. 器官移植, 2025, 16( 3): 482- 488. DOI: 10.12464/j.issn.1674-7445.2025002.
    [19]
    ZHAO ZY, AN XQ, SHI L, et al. Prognostic value of serum prealbumin/total bilirubin ratio in patients with liver failure[J]. China J Mod Med, 2017, 27( 21): 75- 78. DOI: 10.3969/j.issn.1005-8982.2017.21.014.

    赵紫烟, 安雪青, 史丽, 等. 血清前白蛋白/总胆红素比值对肝衰竭患者预后的预测价值[J]. 中国现代医学杂志, 2017, 27( 21): 75- 78. DOI: 10.3969/j.issn.1005-8982.2017.21.014.
    [20]
    KURATA Y, MURAKI S, HIROTA T, et al. Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child-Pugh and MELD scores[J]. Br J Clin Pharmacol, 2022, 88( 8): 3819- 3828. DOI: 10.1111/bcp.15333.
    [21]
    SHI JD, WANG PH, QI Z, et al. Expression of long non-coding RNA HOTAIR in acute liver injury and its intervention on cell ferroptosis and inflammation[J]. China Med, 2023, 18( 8): 1200- 1204. DOI: 10.3760/j.issn.1673-4777.2023.08.017.

    史敬东, 王鹏辉, 齐中, 等. 长链非编码RNA HOTAIR在急性肝损伤中的表达及其对细胞铁死亡及炎症发生的干预作用[J]. 中国医药, 2023, 18( 8): 1200- 1204. DOI: 10.3760/j.issn.1673-4777.2023.08.017.
    [22]
    GUO GY, YANG WT, LI J, et al. The development and appraisal of MELD 3.0 in liver diseases: Good things never come easy[J]. J Clin Transl Hepatol, 2025, 13( 1): 62- 68. DOI: 10.14218/JCTH.2024.00303.
    [23]
    CUI DG, XIAO LY, LIU YF, et al. The predictive value of CTP-MELD scores combined with serum M30 and M65 levels for the short-term prognosis of patients with hepatitis B-related acute-on-chronic liver failure[J]. Chin Hepatol, 2022, 27( 1): 58- 62. DOI: 10.14000/j.cnki.issn.1008-1704.2022.01.016.

    崔大广, 肖玲燕, 刘永福, 等. CTP-MELD评分联合血清M30和M65预测乙型肝炎相关慢加急性肝衰竭短期预后的价值[J]. 肝脏, 2022, 27( 1): 58- 62. DOI: 10.14000/j.cnki.issn.1008-1704.2022.01.016.
    [24]
    CHEN YQ, LI CY, TANG SH. Value of Δtotal bilirubin-alpha-fetoprotein scoring model in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2024, 40( 12): 2399- 2405. DOI: 10.12449/JCH241209.

    陈雨琪, 李春燕, 汤善宏. Δ总胆红素-甲胎蛋白评分模型对HBV相关慢加急性肝衰竭短期预后的预测价值[J]. 临床肝胆病杂志, 2024, 40( 12): 2399- 2405. DOI: 10.12449/JCH241209.
    [25]
    LI WD, LIU WS, RONG YH, et al. Development and validation of a new prognostic model for predicting survival outcomes in patients with acute-on-chronic liver failure[J]. J Clin Transl Hepatol, 2024, 12( 10): 834- 844. DOI: 10.14218/jcth.2024.00316.
    [26]
    GAN YX, OUYANG LY, PAN YX, et al. Predictive value of ICGR15 and ALBI score for post-hepatectomy liver failure and prognosis of hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy[J/OL]. Chin J Hepat Surg(Electronic Edition), 2025, 14( 3): 395- 401. DOI: 10.3877/cma.j.issn.2095-3232.2025.03.010.

    甘翌翔, 欧阳俐颖, 潘扬勋, 等. ICGR15和ALBI评分对肝动脉灌注化疗后肝癌肝切除术后肝衰竭和预后的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14( 3): 395- 401. DOI: 10.3877/cma.j.issn.2095-3232.2025.03.010.
    [27]
    ZHANG H, YANG K, WANG Q, et al. Prealbumin as a predictor of short-term prognosis in patients with HBV-related acute-on-chronic liver failure[J]. Infect Drug Resist, 2023, 16: 2611- 2623. DOI: 10.2147/idr.s402585.
    [28]
    European Association for the Study of the Liver. EASL clinical practice guidelines on acute-on-chronic liver failure[J]. J Hepatol, 2023, 79( 2): 461- 491. DOI: 10.1016/j.jhep.2023.04.021.
    [29]
    CHEN XY, GAO FQ, PAN QL, et al. aCCI-HBV-ACLF: A novel predictive model for hepatitis B virus-related acute-on-chronic liver failure[J]. Aliment Pharmacol Ther, 2025, 61( 2): 286- 298. DOI: 10.1111/apt.18347.
    [30]
    LI C, WANG MD, SUN XD, et al. Development and validation of prealbumin-bilirubin score(preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score[J]. Am J Surg, 2024, 232: 87- 94. DOI: 10.1016/j.amjsurg.2024.01.009.
    [31]
    TREBICKA J, HERNAEZ R, SHAWCROSS DL, et al. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure(ACLF) and the role of biomarkers[J]. Gut, 2024, 73( 6): 1015- 1024. DOI: 10.1136/gutjnl-2023-330584.
    [32]
    CHEN MJ, LI X, TANG SH. Research progress on multidimensional evaluation of liver function in the prognosis of liver failure patients[J]. Clin J Med Offic, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.

    陈美娟, 李雪, 汤善宏. 多维度评估肝功能在肝衰竭患者预后中研究进展[J]. 临床军医杂志, 2023, 51( 9): 901- 903, 907. DOI: 10.16680/j.1671-3826.2023.09.05.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (6) PDF downloads(3) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return